AYTUZ

Aytu BioScience, Inc.

 
Warrants SEC Reporting - Current
OTCQX U.S.
Verified Company Profile 12/15/2016
Contact Info
  • 373 Inverness Parkway
  • Suite 206
  • Englewood, CO 80112

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001385818
Fiscal Year End 6/30
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2015
Employees 57 a/o Dec 01, 2016
Company Officers/Contacts
Joshua Robert Disbrow CEO
Jarrett Disbrow COO
Gregory A. Gould CFO
Jonathan Heath McGrael VP, Sales
Company Directors
Gary Cantrell Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Carl C Dockery
John Donofrio, Jr. Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Michael Emil Macaluso
Service Providers
Accounting/Auditing Firm
EKS&H
7979 E. Tufts Ave.
Suite 400
Denver, CO, 80237
United States
 
Securities Counsel
Wyrick Robbins Yates & Ponton LLP OTCQX Sponsor
4101 Lake Boone Trail
Suite 300
Raleigh, NC, 27607
United States
 
Investor Relations Firm
Tiberland Strategic Advisors
35 West 35th Street
Ste 1102
New York, NY, 10001
United States
 
Company History
  • Sponsored for OTCQX by Wyrick Robbins Yates & Ponton LLP on 12/14/2015.
  • Formerly=Rosewind Corp. until 6-2015
AYTUZ Security Details Other Company Securities
Share Structure
Market Value1 $1,505,061 a/o Mar 24, 2017
Authorized Shares 6,020,245 a/o Dec 01, 2016
Outstanding Shares 6,020,245 a/o Dec 01, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest (%)
Significant Failures to Deliver No

1Market Value calculated only for respective security